Live Breaking News & Updates on Marketing Authorisation Application

Stay updated with breaking news from Marketing authorisation application. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate -Today at 01:01 am

Strong immune response shown in both children and adolescents one month after booster dose in VLA15-221 studyPreviously observed high anamnestic antibody response in adults confirmedVLA15. ....

United States , New York , Annaliesa Anderson , Lyme Borreliosis , Juan Carlos Jaramillo , Joshua Drumm , Pfizer Announce Collaboration To Co , European Medicines Agency , National Surveillance Systems , Head Vaccine Research , Pfizer Inc , Vp Global Communications European Investor Relations , Drug Administration , Exchange Commission , Centers For Disease , Euronext Paris , Geometric Mean Fold Rises , Chief Medical Officer , Mean Titers , Data Safety Monitoring Board , Senior Vice President , Vaccine Against Lyme , Outdoor Recreationists , Biologics License Application , Marketing Authorisation Application , North America ,

Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate

07.09.2023 - Strong immune response shown in both children and adolescents one month after booster dose (month 19) in VLA15-221 studyPreviously observed high anamnestic antibody response in adults confirmedVLA15 well-tolerated in all age groups following booster . ....

United States , Lyme Borreliosis , Juan Carlos Jaramillo , Annaliesa Anderson , Joshua Drumm , National Surveillance Systems , Head Vaccine Research , Drug Administration , Centers For Disease , European Medicines Agency , Vp Global Communications European Investor Relations , Pfizer Announce Collaboration To Co , Exchange Commission , Chief Medical Officer , Mean Titers , Data Safety Monitoring Board , Senior Vice , Vaccine Against Lyme , Outdoor Recreationists , Biologics License Application , Marketing Authorisation Application , North America , Fast Track , Breakthroughs That Change Patient , Pfizer News , Annual Report ,

Pfizer (PFE) and Valneva (VALN) Report Positive Pediatric and Adolescent Phase 2 Booster Results

Pfizer (PFE) and Valneva (VALN) Report Positive Pediatric and Adolescent Phase 2 Booster Results
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Annaliesa Anderson , Juan Carlos Jaramillo , European Medicines Agency , Head Vaccine Research , Pfizer Inc , Drug Administration , Geometric Mean Fold Rises , Chief Medical Officer , Mean Titers , Data Safety Monitoring Board , Senior Vice President , Vaccine Against Lyme , Outdoor Recreationists , Biologics License Application , Marketing Authorisation Application ,

Pfizer, Valneva's Tick-Borne Infection Shot: Companies Say 'Positive' Result For Lyme Disease Vaccine Candidate Booster - Valneva (NASDAQ:VALN), Pfizer (NYSE:PFE)

Valneva SE (NASDAQ: VALN) and Pfizer Inc (NYSE: PFE) released pediatric and adolescent immunogenicity and safety data for their Lyme disease vaccine candidate,  ....

European Medicines Agency , Data Safety Monitoring Board , Biologics License Application , Marketing Authorisation Application ,

Pharming N : Halfjaarlijkse financiële verslaggeving -Today at 03:05 pm

Pharming Group reports second quarter and first half 2023

financial results

RUCONEST® business performed strongly in 2Q 2023;. ....

Noord Holland , Drug Submission To Health Canada , European Commission Decision Reliance Procedure , Patient Program , Therapeutic Goods Administration , Pharming Groupnv , Devices Agency , European Medicines Agency , Regulatory Agency , Drug Administration , Expert Group , Japan Pharmaceuticals , Committee For Human Medicinal Products , Israeli Ministry Of Health , Access Program , Pharming Group , Company Euronext , Ministry Of Health , Executive Officer , Sijmen De Vries , Expanded Access Program , Open Label Extension , Priority Review Voucher , Rare Pediatric Disease Priority Review Voucher , Annual Report , Human Medicinal Products ,